Immunogenicity and Safety of Influenza Virus Vaccine, AdimFlu-S (A/H1N1), in Adults and Elders
NCT01003145
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
292
Enrollment
INDUSTRY
Sponsor class
Conditions
Influenza
Interventions
BIOLOGICAL:
Influenza A (H1N1) 2009 monovalent vaccine, inactivated
Sponsor
Adimmune Corporation